1
00:00:03,200 --> 00:00:06,600
Speaker 1: Global business news twenty four hours a day. If Bloomberg

2
00:00:06,640 --> 00:00:09,720
Speaker 1: dot Com, the Radio plus Mobile act and on your radio.

3
00:00:10,000 --> 00:00:14,080
Speaker 1: This is a Bloomberg business flag from Bloomberg World Headquarters.

4
00:00:14,120 --> 00:00:16,759
Speaker 1: I'm Charlie Pellett Stocks Laura. This update is brought to

5
00:00:16,760 --> 00:00:21,680
Speaker 1: you by Eisner Emperor Accountants and Advisers. Eisener Amper connects

6
00:00:21,760 --> 00:00:25,280
Speaker 1: real estate dealmakers with the resources they need when they

7
00:00:25,320 --> 00:00:28,560
Speaker 1: need it. Connect with Eisener Ramper. Learn more at Eisener

8
00:00:28,600 --> 00:00:31,480
Speaker 1: Amper dot com slash real estate. Now, let's head right

9
00:00:31,520 --> 00:00:34,199
Speaker 1: over to the first Word breaking news desk for today's

10
00:00:34,240 --> 00:00:37,279
Speaker 1: afternoon call. Here he is there, he is Bill Maloney.

11
00:00:37,680 --> 00:00:41,040
Speaker 1: Good afternoon, Charlie. Stocks are under pressure today, helped by

12
00:00:41,080 --> 00:00:44,160
Speaker 1: declines up as much as nine percent in Deutsche Bank.

13
00:00:44,479 --> 00:00:47,199
Speaker 1: About ten hedge funds are said to have cut Deutsche

14
00:00:47,240 --> 00:00:50,760
Speaker 1: Bank's exposure. Dallas, currently down a hundred and sixty three points,

15
00:00:50,760 --> 00:00:53,400
Speaker 1: has to be stropped sixteen and NAZAC is lower by

16
00:00:53,440 --> 00:00:56,640
Speaker 1: forty the small cap SIXANDREA drops seven points, and the

17
00:00:56,720 --> 00:00:59,840
Speaker 1: US ten yield at one point five six percent. Ten

18
00:01:00,000 --> 00:01:02,600
Speaker 1: out of eleven sub sectors are lower, led by declines

19
00:01:02,600 --> 00:01:07,600
Speaker 1: and healthcare, financials and utilities only Telecom gained, doubt, Transports

20
00:01:07,920 --> 00:01:12,120
Speaker 1: game fourteen, utilities fall nine, Nazi botechs were hit hard,

21
00:01:12,200 --> 00:01:15,959
Speaker 1: sink eighty four, and the vix is higher by seventeen percent.

22
00:01:16,440 --> 00:01:19,200
Speaker 1: Leaders to the downside in the Dow included Goldman, Sachs, Merk,

23
00:01:19,360 --> 00:01:23,240
Speaker 1: and Nike. Caterpillar led to the upside, and Jilan News.

24
00:01:23,280 --> 00:01:25,200
Speaker 1: Dow Jones reported that Qualcom is said to be in

25
00:01:25,240 --> 00:01:28,720
Speaker 1: talks to a quiet n XP Semiconductor n XPI gained

26
00:01:28,720 --> 00:01:33,119
Speaker 1: as much as nineteen percent, and finally, Costco reports after

27
00:01:33,160 --> 00:01:36,160
Speaker 1: the bell live from the first breaking news. Ask Bill Maloney, Charlotte,

28
00:01:36,319 --> 00:01:38,320
Speaker 1: thank you very much. Good Maloney will be on Costco

29
00:01:38,360 --> 00:01:40,720
Speaker 1: as we get those numbers and to hear live breaking

30
00:01:40,720 --> 00:01:43,720
Speaker 1: news over your Bloomberg type squawk s q U A

31
00:01:44,080 --> 00:01:47,600
Speaker 1: w K on your terminal stocks. Laura, I'm Charlie Pelt.

32
00:01:47,720 --> 00:01:52,480
Speaker 1: That's a Bloomberg business flash. Now on Bloombern Radio, we

33
00:01:52,640 --> 00:01:55,680
Speaker 1: take stock of healthcare. The tissue of drug pricing has

34
00:01:55,720 --> 00:01:57,920
Speaker 1: been at the forefront, certainly in the political brown for

35
00:01:57,960 --> 00:02:01,040
Speaker 1: the last few months. We're in a very special time

36
00:02:01,360 --> 00:02:04,320
Speaker 1: in the history of the pharmaceutical industry. How many three

37
00:02:04,320 --> 00:02:07,560
Speaker 1: percent of all biotechs that start actually get a drug approved.

38
00:02:07,680 --> 00:02:10,239
Speaker 1: It's a very hard thing to do. Bloomberg takings to

39
00:02:10,480 --> 00:02:15,600
Speaker 1: healthcare and focus on Bloomberg radio the prices of drugs.

40
00:02:15,680 --> 00:02:20,359
Speaker 1: The EpiPen allergy shot, for example, we know, of course

41
00:02:20,400 --> 00:02:22,880
Speaker 1: it's in mentioning controversy because it sells for almost as

42
00:02:22,960 --> 00:02:26,160
Speaker 1: much as the latest iPhone in the United States, actually

43
00:02:26,200 --> 00:02:29,600
Speaker 1: cost less than its leather case in Britain. That's just

44
00:02:29,639 --> 00:02:33,320
Speaker 1: one egregious example of the kind of situations that Michael

45
00:02:33,360 --> 00:02:36,480
Speaker 1: Ray faces and tries to solve with his company are

46
00:02:36,720 --> 00:02:40,680
Speaker 1: X Savings Solutions, where he's founder and CEO based in

47
00:02:40,720 --> 00:02:45,840
Speaker 1: Overland Park, Kansas. So, Michael, uh, it has the problem

48
00:02:45,880 --> 00:02:48,600
Speaker 1: gotten less bad with so much focus on it or

49
00:02:48,680 --> 00:02:53,760
Speaker 1: does it continue to you know, vexed consumers and companies? Well,

50
00:02:53,800 --> 00:02:56,120
Speaker 1: I think, you know, for pleasurely with you guys, I

51
00:02:56,120 --> 00:02:59,240
Speaker 1: think it continues to vex the entire market. And when

52
00:02:59,280 --> 00:03:02,200
Speaker 1: you see store whereas like today, um, you start comparing

53
00:03:02,200 --> 00:03:05,720
Speaker 1: to other countries that at even another level of questioning

54
00:03:06,639 --> 00:03:09,919
Speaker 1: about what, um, what what a price should be. M

55
00:03:10,000 --> 00:03:12,480
Speaker 1: we obviously know we've been paying and uh, you know

56
00:03:12,560 --> 00:03:15,160
Speaker 1: last week my island was in front of Congress, but

57
00:03:15,560 --> 00:03:17,320
Speaker 1: they didn't lower the price. You know, it's it's a

58
00:03:17,320 --> 00:03:19,680
Speaker 1: public scolding, but it's not it's not change in prices.

59
00:03:19,720 --> 00:03:22,880
Speaker 1: So it's concerning. Hey, Michael, you know, one of the

60
00:03:22,880 --> 00:03:24,960
Speaker 1: things I want to point to out is that federal

61
00:03:25,080 --> 00:03:29,160
Speaker 1: health regulators have said that my line is short change

62
00:03:29,160 --> 00:03:34,399
Speaker 1: in the government on rebates for sales of EpiPen uh,

63
00:03:34,560 --> 00:03:39,080
Speaker 1: despite the drugmaker having already been admonished that the way

64
00:03:39,120 --> 00:03:43,760
Speaker 1: it classified the device for rebates is in correct. Can

65
00:03:43,800 --> 00:03:47,160
Speaker 1: you explain what's going on? Well, I think that you know,

66
00:03:47,320 --> 00:03:50,560
Speaker 1: the way rebates work is very complex. Um. You know,

67
00:03:50,640 --> 00:03:54,560
Speaker 1: you can call rebates can be called different things. Um,

68
00:03:54,600 --> 00:03:59,000
Speaker 1: they can be called access fees, formulary formulary tr fees,

69
00:03:59,040 --> 00:04:01,560
Speaker 1: they can be called mark could share. But the but

70
00:04:01,640 --> 00:04:03,160
Speaker 1: the you know, at the end of the day, it's

71
00:04:03,200 --> 00:04:05,680
Speaker 1: money that's promised to go back to whoever the payer is,

72
00:04:05,760 --> 00:04:09,000
Speaker 1: in this case the federal government. Um. You know, if

73
00:04:09,160 --> 00:04:10,920
Speaker 1: if that is the case and that's found out to

74
00:04:10,920 --> 00:04:14,160
Speaker 1: be be true, UM, I suspect more problems from Island.

75
00:04:15,160 --> 00:04:19,440
Speaker 1: So tell us more about how your company is working

76
00:04:19,480 --> 00:04:24,560
Speaker 1: to solve this problem. Yeah, great, great question. Um. You know, so,

77
00:04:24,680 --> 00:04:26,599
Speaker 1: really what we're trying to do is we're trying to

78
00:04:26,600 --> 00:04:30,560
Speaker 1: put information in the hands of consumers. Americans are you know,

79
00:04:30,720 --> 00:04:34,719
Speaker 1: really good consumers and nearly everything they buy except prescription drugs.

80
00:04:35,160 --> 00:04:36,920
Speaker 1: And the reason that they're not is not because they

81
00:04:36,920 --> 00:04:39,719
Speaker 1: don't want to, it's because it's too hard. Um, there's

82
00:04:39,760 --> 00:04:43,880
Speaker 1: there's a lack of information available. UM, there's certain players

83
00:04:43,920 --> 00:04:46,880
Speaker 1: in the supply chain that that wants, UM, you know,

84
00:04:46,920 --> 00:04:49,839
Speaker 1: access to certain information so that so that you know,

85
00:04:49,920 --> 00:04:52,520
Speaker 1: consumer will buy an f depen instead of another product

86
00:04:52,520 --> 00:04:55,360
Speaker 1: on the market, UM, another FNF from product that maybe

87
00:04:55,400 --> 00:04:57,520
Speaker 1: a third of the price. And so you know, what

88
00:04:57,600 --> 00:04:59,560
Speaker 1: we really try to do is put that information back

89
00:04:59,560 --> 00:05:01,839
Speaker 1: in the hands consumers, let them know about all of

90
00:05:01,880 --> 00:05:05,160
Speaker 1: their options, and in turn they act more like consumers.

91
00:05:05,200 --> 00:05:07,560
Speaker 1: They save money, the health plan saves money, and their

92
00:05:07,560 --> 00:05:11,720
Speaker 1: employers saves money. So what the people who use an EpiPen,

93
00:05:12,000 --> 00:05:14,840
Speaker 1: what do they take away from this? Yeah, you know,

94
00:05:15,320 --> 00:05:17,960
Speaker 1: it's a great, great question, and I think that um,

95
00:05:18,000 --> 00:05:19,719
Speaker 1: you know, this is something that's been missing from the

96
00:05:19,760 --> 00:05:21,880
Speaker 1: conversation is the fact that there is an F and

97
00:05:21,920 --> 00:05:25,200
Speaker 1: F from product available. It's an auto injector product. Um,

98
00:05:25,240 --> 00:05:27,240
Speaker 1: it's a fraction of the price to EpiPen, and most

99
00:05:27,240 --> 00:05:29,240
Speaker 1: people just don't even know that they have that choice

100
00:05:30,080 --> 00:05:34,039
Speaker 1: miland was very effective the same. And what about the cost,

101
00:05:34,120 --> 00:05:35,920
Speaker 1: because I know that I was looking at the cost

102
00:05:36,000 --> 00:05:39,640
Speaker 1: of the EpiPen. It now sells for more than six

103
00:05:39,720 --> 00:05:42,920
Speaker 1: hundred dollars per two pack, or more than three dollars

104
00:05:42,960 --> 00:05:45,640
Speaker 1: a piece. Obviously, when they bought this product back in

105
00:05:45,720 --> 00:05:48,480
Speaker 1: two thousand and seven, they saw they were selling this

106
00:05:48,520 --> 00:05:52,320
Speaker 1: product was selling for fifty seven dollars each. Yeah, So

107
00:05:52,360 --> 00:05:55,200
Speaker 1: I think that there's there's really two important points there.

108
00:05:55,240 --> 00:05:58,520
Speaker 1: The first is UM, you know, they rose prices because

109
00:05:59,000 --> 00:06:01,480
Speaker 1: they thought they could UM and in a free market,

110
00:06:01,640 --> 00:06:05,920
Speaker 1: you know, we reward stockholders for that. On the flip side, UM,

111
00:06:05,960 --> 00:06:09,240
Speaker 1: a lot of information has been withheld from from you

112
00:06:09,400 --> 00:06:12,680
Speaker 1: health plans, employers and their consumers, and so really we

113
00:06:12,720 --> 00:06:14,400
Speaker 1: want to put that information back in the hands of

114
00:06:14,400 --> 00:06:17,320
Speaker 1: the consumer. They can pay half the price that they

115
00:06:17,400 --> 00:06:20,200
Speaker 1: would otherwise for nepeten. And something that we've been doing

116
00:06:20,200 --> 00:06:22,200
Speaker 1: for a couple of years is we've seen this happen,

117
00:06:22,600 --> 00:06:25,120
Speaker 1: is we've been moving and getting that information out to

118
00:06:25,120 --> 00:06:27,919
Speaker 1: our users where they're paying ten dollar co pays for

119
00:06:27,960 --> 00:06:31,880
Speaker 1: a generic from product instead of six price tech that

120
00:06:31,960 --> 00:06:34,839
Speaker 1: the pharmacy counter for the branded so that there's a

121
00:06:34,880 --> 00:06:37,520
Speaker 1: really big difference and that information needs to get to people.

122
00:06:37,880 --> 00:06:42,600
Speaker 1: It sounds like, uh, do you see more, um more

123
00:06:42,680 --> 00:06:45,360
Speaker 1: of the kind of thing you do being done in

124
00:06:45,400 --> 00:06:49,320
Speaker 1: the in the industry by other companies as well? You know,

125
00:06:49,440 --> 00:06:51,880
Speaker 1: I haven't heard of anyone else doing it yet. I suspect,

126
00:06:51,880 --> 00:06:54,200
Speaker 1: you know, there's a lot of interest in this um

127
00:06:54,279 --> 00:06:56,400
Speaker 1: and and one of the things that we take some

128
00:06:56,440 --> 00:06:58,640
Speaker 1: pride in is we do have a granted patent for

129
00:06:58,680 --> 00:07:00,880
Speaker 1: the process, so we think but it's a bit unique,

130
00:07:00,920 --> 00:07:03,520
Speaker 1: and we really want to advocate for the people who

131
00:07:03,560 --> 00:07:07,120
Speaker 1: haven't had the representation for a long time. That's consumers,

132
00:07:07,160 --> 00:07:10,240
Speaker 1: that's their their employers, and the health plans that largely

133
00:07:10,240 --> 00:07:12,360
Speaker 1: have been taken out of the equation in a lot

134
00:07:12,360 --> 00:07:15,640
Speaker 1: of cases. Thank you very much for joining us. Michael

135
00:07:15,720 --> 00:07:19,240
Speaker 1: Ray is the founder and the chief executive of our

136
00:07:19,440 --> 00:07:25,240
Speaker 1: ex Savings Solutions based in Overland Park, Kansas. Of course

137
00:07:25,920 --> 00:07:29,600
Speaker 1: is our healthcare segment. And just to give you an

138
00:07:29,680 --> 00:07:33,800
Speaker 1: update on the EpiPen program, Senate staffers and two U

139
00:07:33,880 --> 00:07:36,920
Speaker 1: S senators have called for an increased investigation of the

140
00:07:36,960 --> 00:07:46,080
Speaker 1: classification of EpiPens. You're listening to taking stock This is Bloomberg, Bloomber.

141
00:07:46,120 --> 00:07:48,240
Speaker 1: Taking stock is brought you by Bank of America Mery

142
00:07:48,320 --> 00:07:51,720
Speaker 1: Lynch's Global Cash management solutions, helping you manage, protect an investor,

143
00:07:51,760 --> 00:07:54,560
Speaker 1: global cash wherever the road to growth leads. That's the

144
00:07:54,600 --> 00:07:57,480
Speaker 1: power of global connections. Bank of America North America member

145
00:07:57,520 --> 00:07:58,040
Speaker 1: f d I C